INS and polycystic ovary syndrome: Metformin (MET) is a widely used insulin-sensitizing agent, which was firstly administered in obese PCOS women in 1994 to reduce serum levels of insulin and androgen and regularize the cycle of menses, but some patients worry about the potential adverse effects.